CBD Life Sciences, Inc.
(CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG
Pain Relief Cream, Setting the Stage for Unprecedented
Growth
Walmart's market cap as of
September 2024 is $635.50 billion, making it the 13th most valuable
company in the world. This partnership offers CBD Life Sciences
unprecedented exposure on a global retail platform.
SCOTTSDALE, AZ -- October 22, 2024 -- InvestorsHub NewsWire --
CBD Life Sciences, Inc. (OTC:
CBDL) proudly announces a monumental step forward in its rapid
growth trajectory—approval to sell its signature 3000MG Pain Relief
Cream on Walmart Marketplace. This landmark achievement not only
marks a new era of accessibility for consumers but also signals CBD
Life Sciences' aggressive push to dominate the multibillion-dollar
CBD market. With more top-selling products set to launch on
Walmart's expansive e-commerce platform, CBDL is well-positioned to
drive revenue growth and enhance shareholder value.
A Major Milestone in CBDL's Market Strategy
Walmart Marketplace approval represents a significant leap
forward in CBDL's mission to bring cutting-edge, scientifically
formulated CBD products to the mass market. The company's 3000MG
Pain Relief Cream is a high-demand item, offering one of the most
potent and effective topical solutions available for chronic pain,
muscle aches, and joint discomfort. Boasting the maximum
concentration of CBD, this product is specifically designed to
offer rapid, long-lasting relief, making it a go-to option for
consumers seeking natural alternatives to traditional pain
management.
"This approval from Walmart Marketplace is a game-changer for
our company and our customers," said Lisa Nelson, President and CEO
of CBDL. "Our 3000MG Pain Relief Cream is formulated with
nanotechnology to enhance bioavailability and absorption, ensuring
faster and more effective pain relief. Bringing this product to
Walmart's vast customer base allows us to meet increasing demand
for natural, safe, and potent solutions to pain management."
The Explosive Growth of CBD: A Market Primed for
Opportunity
The global CBD industry is in the midst of unprecedented growth,
with the market projected to reach $47.22 billion by 2028, growing
at a compound annual growth rate (CAGR) of 21.2% from 2023 to 2030.
Pain relief remains one of the most common reasons people turn to
CBD, with studies showing that 62% of CBD users report its
effectiveness in alleviating pain. In the U.S. alone, it's
estimated that chronic pain affects 50 million adults, underscoring
the vast market opportunity for CBDL's innovative solutions.
CBD Life Sciences' relentless focus on product development and
scientific innovation has already generated remarkable results.
Since February 2024, the company has achieved a revenue increase of
1405.46%, positioning it among the fastest-growing CBD companies in
the industry. This Walmart Marketplace approval is expected to
accelerate that growth even further, as CBDL continues to secure
key distribution channels that bring its top-tier products directly
to consumers.
Aggressive Expansion Strategy: More Products, More
Opportunities
In addition to the 3000MG Pain Relief Cream, CBDL has plans to
introduce several more of its best - selling products to Walmart
Marketplace in the coming months, further expanding its presence in
the retail sector. With each new product launch, the company is set
to capture a larger share of the booming CBD market while
delivering on its commitment to boost shareholder returns.
"This is just the beginning," Nelson continued. "Our approval
for the Walmart Marketplace not only enhances our ability to reach
millions of new customers but also reinforces our commitment to
increasing revenue, building brand awareness, and consistently
delivering shareholder value. As we continue to innovate and expand
our product lines, we expect to see significant growth in our
market share, revenue streams, and overall industry impact."
Commitment to Shareholder Value and Long-Term
Success
CBD Life Sciences has long maintained a focus on delivering
exceptional value to its shareholders. By securing distribution on
Walmart Marketplace, the company is reinforcing its long-term
growth strategy and demonstrating its commitment to becoming a
leader in the CBD industry. As CBDL expands its product offerings
and strengthens its retail partnerships, investors can expect
continued strong performance and value creation.
"We understand the importance of building trust with our
shareholders and investors," added Nelson. "Every milestone we
achieve, including this Walmart Marketplace launch, reflects our
dedication to transparency, growth, and long-term profitability. As
we continue to expand our product portfolio and retail footprint,
we're focused on driving results that benefit all
stakeholders."
A Bright Future for CBD Life Sciences
The approval to sell CBD Life Sciences' 3000MG Pain Relief Cream
on Walmart Marketplace is a key component of the company's larger
vision: to become a household name in the wellness industry. With
aggressive growth strategies, innovative product formulations, and
a commitment to meeting the evolving needs of consumers, CBDL is
poised to lead the CBD revolution. This latest achievement sets the
stage for exciting developments in the months ahead as the company
continues to add more top-tier products to Walmart's platform and
beyond.
For more information about CBD Life Sciences, Inc. and its
product offerings, visit www.thecbdvault.com
About CBD Life Sciences, Inc.
CBD Life Sciences, Inc. (OTC:
CBDL) is a leading innovator in the CBD and wellness industry,
committed to creating high-quality, scientifically backed products
that promote health and well - being. From pain relief to overall
wellness, CBD Life Sciences strives to deliver top-tier solutions
that meet the needs of today's consumers.
Follow our social media for the latest updates!
X:
https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the
matters discussed in this press release are forward-looking
statements. Actual results may differ materially from those
described in forward-looking statements and are subject to risks
and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings
with OTC Markets, which may identify specific factors that may
cause actual results or events to differ materially from those
described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are
based on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in the
economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking ability to secure and maintain strategic
relationships and distribution agreements. The Company disclaims
any intention or obligation to update or revise any forward-looking
statements.
Contact Information Lisa Nelson
CEO cbdvaultaz@gmail.com 4802091720
